Logo image
Antihuman leukocyte antigen antibody-induced autoimmunity: role in chronic rejection
Journal article   Peer reviewed

Antihuman leukocyte antigen antibody-induced autoimmunity: role in chronic rejection

Dilip S. Nath, Haseeb Illias Basha and Thalachallour Mohanakumar
Current opinion in organ transplantation, Vol.15(1), pp.16-20
02/01/2010
PMID: 19898237

Abstract

Life Sciences & Biomedicine Science & Technology Transplantation
Purpose of review We provide evidence for the role of de-novo development of immune responses to self-antigens in the posttransplant period and its possible induction by alloimmunity in the pathogenesis of chronic rejection following lung, heart and kidney transplantation. The present review details recent findings for the two distinct yet interdependent immune processes in the immunopathogenesis of chronic rejection. Recent findings The contribution of both humoral and cell-mediated alloimmune responses against mismatched donor histocompatibility antigens (HLA) in the pathogenesis of chronic rejection is well established. Recent studies have focused on development of immune responses to self-antigens during the posttransplant period and its correlation with chronic rejection. These self-antigens include myosin and vimentin in cardiac, K-alpha-1-tubulin and collagen-V in lung and angiotensin II type 1 receptor, collagen-IV and VI in kidney transplants. During the posttransplant period, the development of immune responses to self-antigens is facilitated by induction of a distinct subset of autoreactive T-helper cells referred to as Th17 cells. Summary Following organ transplantation, tissue injury and remodeling inflicted by antibodies (Abs) to HLA antigens is conducive to develop autoimmunity. Abs to HLA and self-antigens are detectable in the serum of transplant recipients who develop chronic rejection. Anti-HLA Abs are often present transiently but precede the development of Abs to self-antigens.

Metrics

1 Record Views

Details

Logo image